Mirvaso (Page 4 of 4)
PRINCIPAL DISPLAY PANEL 30g Pump Carton
Rx Only
NDC 0299-5980-35
Mirvaso®
(brimonidine) topical gel, 0.33%*
PUMP
*Each gram of Mirvaso topical gel contains 5 mg of brimonidine tartrate, equivalent to 3.3 mg of brimonidine free base
For Topical Use Only
Keep Out of Reach of Children
GALDERMA
NET WT. 30 g
Not for oral, ophthalmic or intravaginal use.
To Open Pump: Push the cap down while turning it counter-clockwise to remove the cap.
Usual Dosage: Apply a pea-size amount once daily to each of the five areas of the face (forehead, chin, nose, and each cheek) avoiding the eyes and lips. See package insert for complete prescribing information.
Each gram contains the active ingredient brimonidine tartrate 5mg with the inactive ingredients carbomer homopolymer type B, glycerin, methylparaben, phenoxyethanol, propylene glycol, purified water, sodium hydroxide, and titanium dioxide.
Storage: Store at 20° to 25°C (68° to 77°F), excursions permitted between 15° and 30°C (59° and 86°F). [See USP Controlled Room Temperature].
See bottom of carton for lot number and expiration date.
All trademarks are the property of their respective owners.
Marketed by:
GALDERMA LABORATORIES, L.P.
Dallas, TX 75201 USA
Made in CanadaP52848-3
MIRVASO brimonidine tartrate gel | |||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||
|
Labeler — Galderma Laboratories, L.P. (047350186) |
Establishment | |||
Name | Address | ID/FEI | Operations |
G Production Inc. | 251676961 | manufacture (0299-5980) |
Revised: 12/2022 Galderma Laboratories, L.P.
All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.